China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that the National Medical Products Administration (NMPA) has accepted its market approval filing for a transcatheter aortic valve system for review.
Product Features and Clinical Applications
The product is designed for patients with severe aortic valve stenosis who are at high risk and require valve replacement surgery. It boasts a unique valve leaf bracket structure and connection process, along with multiple specifications, which enable it to address the clinical needs of various lesions. The design aims to reduce the occurrence of complications such as perivalve leakage and enhance the durability performance of the valve system.- Flcube.com
